Kezar Life Sciences (KZR) Retained Earnings (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Retained Earnings for 5 consecutive years, with $14000.0 as the latest value for Q3 2025.
- Quarterly Retained Earnings fell 86.92% to $14000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $14000.0 through Sep 2025, down 86.92% year-over-year, with the annual reading at -$162000.0 for FY2024, 24.62% down from the prior year.
- Retained Earnings hit $14000.0 in Q3 2025 for Kezar Life Sciences, up from -$267000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $107000.0 in Q3 2024 to a low of -$451.1 million in Q1 2025.
- Historically, Retained Earnings has averaged -$123.9 million across 5 years, with a median of -$830000.0 in 2023.
- Biggest five-year swings in Retained Earnings: crashed 140400.0% in 2022 and later skyrocketed 115.57% in 2024.
- Year by year, Retained Earnings stood at -$180.7 million in 2021, then crashed by 37.77% to -$248.9 million in 2022, then surged by 99.95% to -$130000.0 in 2023, then decreased by 24.62% to -$162000.0 in 2024, then surged by 108.64% to $14000.0 in 2025.
- Business Quant data shows Retained Earnings for KZR at $14000.0 in Q3 2025, -$267000.0 in Q2 2025, and -$451.1 million in Q1 2025.